Evidence map›Paper›PMID 33408227›Full record

ArticlemSphere2021

Identification of Nasal Gammaproteobacteria with Potent Activity against Staphylococcus aureus: Novel Insights into the "Noncarrier" State.

Amy L Cole, Meera Sundar, Ana Lopez, Anna Forsman, Shibu Yooseph, Alexander M Cole

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in mSphere, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Nasal microbiome inhabitants with anti-Microbiology spectrum · 2025
    Article
  3. Article
  4. Article
  5. mBio · 2023
    Article
  6. Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Amy L ColeBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, Florida, USA.
Meera SundarBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, Florida, USA.
Ana LopezBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, Florida, USA.
Anna ForsmanGenomics and Bioinformatics Faculty Cluster, University of Central Florida, Orlando, Florida, USA.
Shibu YoosephDepartment of Computer Science, College of Engineering and Computer Science, University of Central Florida, Orlando, Florida, USA.
Alexander M ColeBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, Florida, USA acole@ucf.edu.ORCID 0000-0003-0134-3753
University of Central Florida · US

Funding

Development of nonhuman primate model of S. aureus nasal carriageR21AI119835 · NIAID · UNIVERSITY OF CENTRAL FLORIDA · PI COLE, ALEXANDER MICHAEL · 2015 to 2016
$458k
NIAID NIH HHS R21 AI119835
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AntibiosisAnti-Bacterial AgentsCarrier StateCells, CulturedEpithelial CellsGammaproteobacteriaHumansMicrobiotaNasal CavityStaphylococcus aureusAnti-Bacterial Agentsbacterial interferencemicrobiomenasal carriageStaphylococcus aureus

Identifiers

PMID33408227
PMCPMC7802429
OpenAlexW3118662732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.